104 related articles for article (PubMed ID: 34944413)
1. Hyperlipidemia Determines Dysfunctional HDL Production and Impedes Cholesterol Efflux in the Small Intestine: Alleviation by Ginger Extract.
Barbalata T; Deleanu M; Carnuta MG; Niculescu LS; Raileanu M; Sima AV; Stancu CS
Mol Nutr Food Res; 2019 Oct; 63(19):e1900029. PubMed ID: 31295384
[TBL] [Abstract][Full Text] [Related]
2. PON1 has palmitoyl-protein thioesterase (PPT) activity, and can affect the presence of SR-B1 on the endothelial cell membrane.
Ashkar R; Khattib A; Musa S; Goldberg D; Khatib S
Biofactors; 2024; 50(3):608-618. PubMed ID: 38135490
[TBL] [Abstract][Full Text] [Related]
3. Importance of Polymorphisms in the Gene of Paraoxonase-1 (SNP rs662) and Apolipoprotein A-I (SNP rs670 and rs5069) in Non-Smoking and Smoking Healthy Subjects and Patients with Acute Pancreatitis.
Ściskalska M; Milnerowicz H
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360205
[TBL] [Abstract][Full Text] [Related]
4. The Role of Polyphenols in Modulating PON1 Activity Regarding Endothelial Dysfunction and Atherosclerosis.
Sirca TB; Mureșan ME; Pallag A; Marian E; Jurca T; Vicaș LG; Tunduc IP; Manole F; Ștefan L
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474211
[TBL] [Abstract][Full Text] [Related]
5. Novel expression cassettes for increasing apolipoprotein AI transgene expression in vascular endothelial cells.
Sethuraman M; Dronadula N; Bi L; Wacker BK; Knight E; De Bleser P; Dichek DA
Sci Rep; 2022 Dec; 12(1):21079. PubMed ID: 36473901
[TBL] [Abstract][Full Text] [Related]
6. Multivalent Display of ApoAI Peptides on the Surface of Tobacco Mosaic Virus Nanotubes Improves Cholesterol Efflux.
Shin MD; Ortega-Rivera OA; Steinmetz NF
Bioconjug Chem; 2022 Oct; 33(10):1922-1933. PubMed ID: 36191144
[TBL] [Abstract][Full Text] [Related]
7. Dicarbonyl-modified lipoproteins contribute to proteinuric kidney injury.
Zhong J; Yang HC; Shelton EL; Matsusaka T; Clark AJ; Yermalitsky V; Mashhadi Z; May-Zhang LS; Linton MF; Fogo AB; Kirabo A; Davies SS; Kon V
JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36125905
[TBL] [Abstract][Full Text] [Related]
8. The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells.
Huang K; Pitman M; Oladosu O; Echesabal-Chen J; Vojtech L; Esobi I; Larsen J; Jo H; Stamatikos A
Diseases; 2023 Jun; 11(3):. PubMed ID: 37489440
[TBL] [Abstract][Full Text] [Related]
9. Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.
Luoma PV
Curr Mol Med; 2011 Jul; 11(5):391-400. PubMed ID: 21568932
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation.
Dietrich E; Jomard A; Osto E
Front Cardiovasc Med; 2022; 9():989428. PubMed ID: 36304545
[TBL] [Abstract][Full Text] [Related]
11. Transcription factors as drug targets: opportunities for therapeutic selectivity.
Butt TR; Karathanasis SK
Gene Expr; 1995; 4(6):319-36. PubMed ID: 7549464
[TBL] [Abstract][Full Text] [Related]
12. A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease.
Rani A; Marsche G
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242746
[TBL] [Abstract][Full Text] [Related]
13. Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review.
Kunachowicz D; Ściskalska M; Kepinska M
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833509
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/dCas9 Transcriptional Activation of Endogenous Apolipoprotein AI and Paraoxonase 1 in Enterocytes Alleviates Endothelial Cell Dysfunction.
Toma L; Barbălată T; Sanda GM; Niculescu LS; Sima AV; Stancu CS
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944413
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein AI and high-density lipoprotein have anti-inflammatory effects on adipocytes via cholesterol transporters: ATP-binding cassette A-1, ATP-binding cassette G-1, and scavenger receptor B-1.
Umemoto T; Han CY; Mitra P; Averill MM; Tang C; Goodspeed L; Omer M; Subramanian S; Wang S; Den Hartigh LJ; Wei H; Kim EJ; Kim J; O'Brien KD; Chait A
Circ Res; 2013 May; 112(10):1345-54. PubMed ID: 23501697
[TBL] [Abstract][Full Text] [Related]
16. Clusterin, paraoxonase 1, and myeloperoxidase alterations induce high-density lipoproteins dysfunction and contribute to peripheral artery disease; aggravation by type 2 diabetes mellitus.
Sanda GM; Toma L; Barbalata T; Moraru OE; Niculescu LS; Sima AV; Stancu CS
Biofactors; 2022 Mar; 48(2):454-468. PubMed ID: 34741558
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine.
Rosenblat M; Vaya J; Shih D; Aviram M
Atherosclerosis; 2005 Mar; 179(1):69-77. PubMed ID: 15721011
[TBL] [Abstract][Full Text] [Related]
18. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.
Berrougui H; Khalil A
Rejuvenation Res; 2009 Apr; 12(2):117-26. PubMed ID: 19405812
[TBL] [Abstract][Full Text] [Related]
19. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
Soran H; Schofield JD; Liu Y; Durrington PN
Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
